Dr. Dan Iosifescu is Professor of Psychiatry at the New York University School of Medicine and Director of the Clinical Research Division at the Nathan Kline Institute. His research is focused on novel pharmacological treatments (such as ketamine and other glutamatergic drugs) and devices (such as photobiomodulation with near infrared light and novel forms of magnetic stimulation) for patients with severe mood (major depression and bipolar disorder) and cognitive disorders (Alzheimer’s disease). In his research Dr. Iosifescu uses neuroimaging (MRI, MRS, PET) and neurophysiology (quantitative EEG) techniques to evaluate structural, biochemical, and functional brain abnormalities in mood and cognitive disorders, and their impact on clinical treatment.
After completing medical studies at the “Carol Davila” University in Bucharest, Romania, Dr. Iosifescu completed his internship and psychiatry residency at Massachusetts General Hospital (MGH) and McLean Hospital. His research training included a neuroimaging fellowship in the Neuroscience Laboratory at Harvard Medical School, a psychopharmacology fellowship in the MGH Mood and Anxiety Disorders Institute, and a fellowship in the Clinical Investigator Training Program at Harvard and MIT. In parallel Dr. Iosifescu received a Master of Medical Science degree from Harvard University. Until 2010 Dr. Iosifescu was Associate Professor of Psychiatry at Harvard Medical School and a mood disorder researcher at MGH; between 2010 and 2017 he was the Director of the Mood and Anxiety Disorders Program and Associate Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai.
Dr. Iosifescu has authored more than 230 original papers in peer-reviewed medical journals, more than 50 reviews and book chapters and more than 150 abstracts. He received a series of prestigious prizes: the NARSAD Young Investigator Award (which he received twice), the Kaplen Award and the Livingston Award from Harvard Medical School, the American Psychiatric Association Young Investigator Award, the NCDEU New Investigator Award, and a National Institute for Mental Health K23 Career Development Award. Dr. Iosifescu was also designated among the “Best Doctors in America” in all editions of “Best Doctors” since 2005 and among the Top Doctors in Castle Connolly’s psychiatry section.
